North America Medical Collagen Market

Market Introduction

Medical collagen is widely used in applications such as wound healing, tissue engineering, reconstructive surgeries, bone grafts, and cosmetic surgeries. It is bio-compatible material with low immunogenicity. Collagen has good hemostatic properties and facilitates wound healing. Collagen is used in cell cultures as it supports cell proliferation in lattice structures and cell binding domain. Hence collagen is widely used as a biomaterial in the medical industry.

North America Medical Collagen Strategic Insights

Strategic insights for the North America Medical Collagen provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America Medical Collagen Report Scope

North America Medical Collagen Regional Insights

The geographic scope of the North America Medical Collagen refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The North America medical collagen market is expected to reach US$ 441.84 million in 2028 from US$ 285.22 million in 2021; it is estimated to grow at a CAGR of 6.5% from 2021 to 2028. The growth of the North America medical collagen market is attributable to growing applications of collagen in the medical industry, and rising FDA approvals and product launches. However, availability of reliable substitute biomaterials other than medical collagen are hampering the growth of the market.

As collagen is weakly antigenic and biodegradable, it has excellent biocompatibility. Thus, making it a primary resource in medical applications. Collagen is one of the key constituents in cosmetic formulations as it has moisturizing, regenerating, and film-forming properties. Moreover, collagen fillers are widely used in aesthetic medicines. The subcutaneous injection of soluble collagen enhances the quality and density of the skin, thereby repairing dermatological defects. Collagen-based biomaterials have a wide range of applications in vivo and in vitro. Collagen has been widely used to develop synthetic bone graft substitutes for spine, extremities, and dental requirements. Further, collagen scaffolds are developed to mimic and regenerate native tissues and are being rapidly adopted for cartilage repair. Collagen is naturally involved in the wound-healing process, and the use of collagen-based wound dressing offers several advantages for acute and chronic wound closure. Additionally, collagen dressings can control the moisture of the wound either by absorbing or providing moisture. Thus, collagen is widely used in dressings, particles, and flowable scaffolds to treat acute and chronic wounds. This wide range of applications of collagen in the medical industry is driving the growth of the market. Various players operating in the medical collagen market are developing and launching new products to expand their geographic reach and capacity to cater to a large customer base. Thus, constant advancements in products and approvals from regulatory bodies are factors further driving the growth of the medical collagen market.

As per the IRI data, demand for various dietary supplements increased at unprecedented rates owing to the onset of the COVID-19 pandemic in the US. The total supplement sales increased by 6% during the first week of March 2020. Also, due to social distancing practices, consumers are experiencing changes in their daily routines involving grooming and skincare. This has led to an increased demand for nutricosmetics that can be used at home. This is likely to favor the growth of skincare collagen products. Hence, COVID-19 has had a positive impact on the North America medical collagen market.

Key Market Segments

The North America medical collagen market, by source, is segmented into bovine, porcine, and others. The bovine segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR during the forecast period.

The North America medical collagen market, by product, is segmented into gelatine, hydrolysed collagen, native collagen, and others. The gelatine segment held the largest share of the market in 2020 and is expected to register the highest CAGR in the market during the forecast period.

Based on application, the North America medical collagen market is segmented into haemostats, vascular grafts, tissue scaffolds, cartilage repair, wound care, bone grafts, diagnostics, and others. The wound care segment held the largest share of the market in 2020. However, the bone grafts segment is estimated to register the highest CAGR during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the North America medical collagen market are the National Health Surveillance Agency (ANVISA), Food and Drug Administration (FDA), and United Nations Population Fund (UNFPA).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of North America medical collagen market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the North America medical collagen market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America medical collagen market.

NORTH AMERICA MEDICAL COLLAGEN MARKET SEGMENTATION

By Source

• Bovine
• Porcine
• Others

By Product

• Gelatine
• Hydrolysed Collagen
• Native Collagen
• Others

By Application

• Wound Care
• Bone Grafts
• Tissue Scaffolds
• Cartilage Repair
• Haemostats
• Diagnostics
• Vascular Grafts
• Other

By Country

• US
• Canada
• Mexico

Company Profiles

• DSM
• Collagen Solutions Plc
• Innocoll Pharmaceuticals
• ENCOLL Corp
• CollPlant Biotechnology
• GELITA AG
• Collagen Matrix, Inc.
• Integra Life Sciences Corporation
• Croda International plc